2023 PCE Oncology Fall Conferences - Solid Tumor Day

This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice for oncology NPs, PAs, and nurses. Review the latest evidence-based strategies for the contemporary care of your patients with breast cancer, gastric cancer, melanoma, and non-small-cell lung cancer via downloadable slides from CCO and PCE.

Share

Program Content

Activities

Combo IO-CT for Nurses
Combination Immunotherapy and Chemotherapy Regimens in NSCLC: Clinical Practice Recommendations for Oncology Nurses
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 28, 2023

View Activity

Activities

High-Risk EBC
New Options in High-Risk Early Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 27, 2023

View Activity
Targeted Therapy in EBC
My Experience Managing Key Adverse Events With Oral Targeted Therapy for High-Risk Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2023

View Activity
PCE oncology fall 2023 BC
New Options in High-Risk Early Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2023

Expires: December 10, 2024

View Activity

Activities

Gastric Cancer
Maximizing Benefit With the Expanding Options for Gastric Cancer: Patient Selection and Management
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 27, 2023

View Activity
PCE oncology fall 2023 GC
Maximizing Benefit With the Expanding Options for Gastric Cancer: Patient Selection and Management
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2023

Expires: December 10, 2024

View Activity
Gastric Cancer: FAQs
Maximizing Benefit With the Expanding Options for Gastric Cancer: Expert Answers to Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2023

View Activity

Activities

Melanoma Adjuvant Immunotherapy
Driving Improved Outcomes in Resectable Melanoma: Pathways for Optimized Adjuvant Immunotherapy Strategies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 28, 2023

View Activity

Faculty

cover img faculity

James M. Cleary, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research
Gastrointestinal Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Marianne Davies, DNP, ACNP, FAAN

Associate Professor
Yale School of Nursing
Senior Advanced Practice Nurse
Smilow Cancer Hospital at
Yale New Haven
Yale Comprehensive Cancer Center
New Haven, Connecticut

cover img faculity

Michael A. Davies, MD, PhD

Professor and Chair, Department of Melanoma Medical Oncology
Professor, Translational Molecular Pathology and Genomic Medicine
Anne and John Mendelsohn Chair in Cancer Research
University of Texas, MD Anderson Cancer Center
Houston, Texas

cover img faculity

Kevin Kalinsky, MD, MS

Professor of Medicine
Director, Glenn Family Breast Center
Winship Cancer Institute
Emory University
Atlanta, Georgia

cover img faculity

Kathleen Madden, FNP, MSN, AOCNP, APHN

Melanoma Program
NYU Langone Perlmutter Cancer Center
New York, NY

cover img faculity

Rasheda Persinger, MSN, AGNP-C, AOCNP

Medical Oncology Lead Nurse Practitioner
Sidney Kimmel Cancer Center Sibley Memorial Hospital
Johns Hopkins System
Washington, DC

cover img faculity

April Salama, MD

Associate Professor of Medicine
Division of Medical Oncology
Director, Melanoma Program
Duke Cancer Institute
Durham, North Carolina

Provided by

ProCE Banner
ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) and Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca; Bristol Myers Squibb; Merck Sharp & Dohme, LLC; and Regeneron Pharmaceuticals, Inc.

AstraZeneca

Bristol Myers Squibb

Merck Sharp & Dohme, LLC

Regeneron Pharmaceuticals, Inc

Partners

AIM at Melanoma Foundation

ProCE Banner